-
Featured Authors
-
Archives
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: FDA
Pro-GMO Labeling Business Faces Own Labeling Dilemma
“Dr. Bronner’s should spend more time worrying about their own labels.” The Center for Consumer Freedom recently published an interesting piece on Dr. Bronner’s Magic Soaps and his run in with the FDA. You may know that Dr. Bronner’s Magic Soaps is an outspoken advocate of the scientifically suspect “GMO labeling” movement. In a warning letter to the company, the FDA states: “Based on our review of the product label, we have determined that your product is promoted for conditions that Read More >
Docs to FDA: Biosimilars should have different names than branded drugs
Yesterday, Fierce Biotech highlighted a letter written by more than 10 medical associations and 20 individual specialists to FDA Commissioner Margaret Hamburg saying that biosimilars “must have distinguishable nonproprietary names. The FDA drafted a set of rules for biosimilars in 2012, sparking a debate on whether those drugs should carry the same generic names as the originator products. Now, some doctors are weighing in on the issue, urging the FDA to require biosimilars to have distinguishable names. The physicians argued that using different Read More >
The “Other Issues to Worry About” vs. GMO’s
We don’t label foods for pesticides, fertilizers or these other “conventional” food-production technologies. Only genetically engineered food is considered unconventional; it’s what the big labeling-law movement is all about these days. Why is that? Largely because groups of people have managed to make it an issue, not because it’s the one big dangerous thing happening with our food – The LA Times, Karin Klein Last week, the Los Angeles Times released an opinion blog with Read More >
Forbes: Faster FDA Approvals Have Not Caused More Drug Safety Problems
In 1992, Congress, industry, and the FDA worked together to create the Prescription Drug User Fee Act (PDUFA). This program ensures that FDA has the ability to hire additional reviewers to expedite the drug review process by having industry pay “user fees.” Recently, attention has been given to a flawed study in the August 2014 issue of Health Affairs, which has some critics claiming that PDUFA fees are biasing FDA review decisions. The study looked at Read More >
Puerto Rico: The New Hub for Ag-Biotech Innovation
“Biotechnology Innovation—the union of scientific discovery and capital can flourish in a supportive research and regulatory environment. Key policy principles will help facilitate the discovery, development, and commercialization of biotech products that will fight disease, feed the hungry and improve the environment”-BIO 2014 A quote that wholly describes the agricultural climate of Puerto Rico. The country offers a perfect location, climate, great soil quality, inviting regulatory system, three pronounced academic/research programs and friendly biotech work Read More >
